Translational Development Acquisition Corp. (NASDAQ:TDACU) Stock Short Interest Report for September

Translational Development Acquisition Corp. (NASDAQ:TDACU) saw a significant drop in short interest in September. As of September 30th, there was short interest totaling 3 shares, a drop of 50.0% from the September 15th total of 6 shares. Based on an average daily trading volume, of 16 shares, the short-interest ratio is presently 0.2 days.

Translational Development Acquisition Stock Performance

Translational Development Acquisition stock remained flat at $11.48 during mid-day trading on Wednesday. 101 shares of the company’s stock were exchanged, compared to its average volume of 1,854. The business’s 50-day simple moving average is $12.12 and its 200-day simple moving average is $11.69. Translational Development Acquisition has a 12 month low of $10.71 and a 12 month high of $17.29.

Translational Development Acquisition Company Profile

Translational Development Acquisition Corporation is a special purpose acquisition company (SPAC) formed to identify and complete a business combination with one or more operating companies. Rather than selling products or services of its own, the company raises capital through a public offering and holds those funds while it evaluates potential merger, acquisition, or similar opportunities.

The company has indicated that it is seeking a target in the healthcare and life sciences sectors, although its business activities may change substantially if it completes a transaction.